Pharmidex attends first Nanomed workshop
Mar 24, 2018

Pharmidex attends the first Nanomed Workshop as a partner of the EU grant. The focus of the meeting was on "Novel Nanoporous Materials for Biomedical Applications".

Pharmidex recently attended the NanoMed Workshop at the University of Alicante which took place on the 21 and 22nd of March.


Please see below for more information about the project. 


The NanoMed project aims to stimulate inter-sectoral and international collaboration within Europe and with an ICPC country, Kazakhstan, in the area of novel nanoporous and nanostructured adsorbents for the treatment of very serious health conditions associated with acute and chronic exposure to external radiation and uptake of heavy metals and radiation as a consequence of accidental, occupational or deliberate activities and events. This can dramatically lower the quality of life of the people affected and at present the treatment available is costly and inefficient. Radioactive contamination is a particularly serious problem in two of the countries participating in this project, namely, Ukraine and Kazakhstan, on large territories of the Chernobyl zone and around Semipalatinsk nuclear test site, respectively. 


For further information please see: www.nanomed-project.eu/content/project

24 Apr, 2024
Pharmidex , in collaboration with colleagues at the University of Brighton, is pleased to announce publication of our latest article
13 Mar, 2024
Uncover valuable insights from a range of sources including plasma, bronchoalveolar lavage fluid, urine, and tissue supernatant with our comprehensive matrix evaluation services.
By Ash Alavijeh 26 Feb, 2024
As an accredited GLP/GCP laboratory, Pharmidex provides comprehensive bioanalytical solutions tailored to meet your specific drug development needs.
More Posts
Share by: